Lee Mi-Jeong, Fried Susan K, Mundt Steven S, Wang Yanxin, Sullivan Sean, Stefanni Alice, Daugherty Bruce L, Hermanowski-Vosatka Anne
Division of Endocrinology, Diabetes and Nutrition, Department of Medicine, University of Maryland at Baltimore, Baltimore, Maryland, USA.
Obesity (Silver Spring). 2008 Jun;16(6):1178-85. doi: 10.1038/oby.2008.207. Epub 2008 Apr 3.
Our main objective was to compare the regulation of cortisol production within omental (Om) and abdominal subcutaneous (Abd sc) human adipose tissue.
Om and Abd sc adipose tissue were obtained at surgery from subjects with a wide range of BMI. Hydroxysteroid dehydrogenase (HSD) activity ((3)H-cortisone and (3)H-cortisol interconversion) and expression were measured before and after organ culture with insulin and/or dexamethasone.
Type 1 HSD (HSD1) mRNA and reductase activity were mainly expressed within adipocytes and tightly correlated with adipocyte size within both depots. There was no depot difference in HSD1 expression or reductase activity, while cortisol inactivation and HSD2 mRNA expression (expressed in stromal cells) were higher in Om suggesting higher cortisol turnover in this depot. Culture with insulin decreased HSD reductase activity in both depots. Culture with dexamethasone plus insulin compared to insulin alone increased HSD reductase activity only in the Om depot. This depot-specific increase in reductase activity could not be explained by an alteration in HSD1 mRNA or protein, which was paradoxically decreased. However, in Om only, hexose-6-phosphate dehydrogenase (H6PDH) mRNA levels were increased by culture with dexamethasone plus insulin compared to insulin alone, suggesting that higher nicotinamide adenine dinucleotide phosphate-oxidase (NADPH) production within the endoplasmic reticulum (ER) contributed to the higher HSD reductase activity.
We conclude that in the presence of insulin, glucocorticoids cause a depot-specific increase in the activation of cortisone within Om adipose tissue, and that this mechanism may contribute to adipocyte hypertrophy and visceral obesity.
我们的主要目的是比较网膜(Om)和腹部皮下(Abd sc)人体脂肪组织中皮质醇生成的调节情况。
从BMI范围广泛的受试者手术中获取Om和Abd sc脂肪组织。在器官培养前后,分别用胰岛素和/或地塞米松处理,然后测量羟类固醇脱氢酶(HSD)活性((3)H-可的松和(3)H-皮质醇的相互转化)及表达情况。
1型HSD(HSD1)mRNA和还原酶活性主要在脂肪细胞内表达,且与两个部位的脂肪细胞大小密切相关。HSD1的表达或还原酶活性在两个部位之间没有差异,而皮质醇失活和HSD2 mRNA表达(在基质细胞中表达)在Om中更高,这表明该部位的皮质醇周转率更高。胰岛素培养可降低两个部位的HSD还原酶活性。与单独使用胰岛素相比,地塞米松加胰岛素培养仅在Om部位增加了HSD还原酶活性。这种还原酶活性的部位特异性增加无法用HSD1 mRNA或蛋白质的改变来解释,相反,其表达反而下降。然而,仅在Om部位,与单独使用胰岛素相比,地塞米松加胰岛素培养使6-磷酸己糖脱氢酶(H6PDH)mRNA水平升高,这表明内质网(ER)中更高的烟酰胺腺嘌呤二核苷酸磷酸氧化酶(NADPH)生成导致了更高的HSD还原酶活性。
我们得出结论,在胰岛素存在的情况下,糖皮质激素会导致Om脂肪组织中可的松激活的部位特异性增加,并且这种机制可能导致脂肪细胞肥大和内脏肥胖。